Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study.

van de Munckhof A, van Kammen MS, Tatlisumak T, Krzywicka K, Aaron S, Antochi F, Arauz A, Barboza MA, Conforto AB, Contreras DG, Heldner MR, Hernández-Pérez M, Hiltunen S, Ji X, Kam W, Kleinig TJ, Kristoffersen ES, Leker RR, Lemmens R, Poli S, Wasay M, Wu T, Yeşilot N, Chen J, Cotelli MS, Demeestere J, Duan J, Ergin N, Freitas TE, Gomes A, den Hertog HM, Lindgren E, Martinez-Majander N, Metanis I, Miraclin A, Rani LJ, Reddy YM, Saleem S, Scutelnic A, Shanmugasundaram S, van den Wijngaard IR, Gençdal IY, van Eekelen R, Vellema J, Arnold M, Neto L, Middeldorp S, de Sousa DA, Jood K, Putaala J, Ferro JM, Coutinho JM, DOAC-CVT investigators

Open source

DOI: 10.1016/s1474-4422(24)00519-2
Published: 2025 Mar
Container: The Lancet. Neurology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1474-4422-24-00519-2,
  title = {Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study.},
  author = {van de Munckhof A and van Kammen MS and Tatlisumak T and Krzywicka K and Aaron S and Antochi F and Arauz A and Barboza MA and Conforto AB and Contreras DG and Heldner MR and Hernández-Pérez M and Hiltunen S and Ji X and Kam W and Kleinig TJ and Kristoffersen ES and Leker RR and Lemmens R and Poli S and Wasay M and Wu T and Yeşilot N and Chen J and Cotelli MS and Demeestere J and Duan J and Ergin N and Freitas TE and Gomes A and den Hertog HM and Lindgren E and Martinez-Majander N and Metanis I and Miraclin A and Rani LJ and Reddy YM and Saleem S and Scutelnic A and Shanmugasundaram S and van den Wijngaard IR and Gençdal IY and van Eekelen R and Vellema J and Arnold M and Neto L and Middeldorp S and de Sousa DA and Jood K and Putaala J and Ferro JM and Coutinho JM and DOAC-CVT investigators},
  year = {2025},
  journal = {The Lancet. Neurology},
  doi = {10.1016/s1474-4422(24)00519-2},
  url = {https://doi.org/10.1016/s1474-4422(24)00519-2}
}

RIS

TY  - JOUR
TI  - Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study.
AU  - van de Munckhof A
AU  - van Kammen MS
AU  - Tatlisumak T
AU  - Krzywicka K
AU  - Aaron S
AU  - Antochi F
AU  - Arauz A
AU  - Barboza MA
AU  - Conforto AB
AU  - Contreras DG
AU  - Heldner MR
AU  - Hernández-Pérez M
AU  - Hiltunen S
AU  - Ji X
AU  - Kam W
AU  - Kleinig TJ
AU  - Kristoffersen ES
AU  - Leker RR
AU  - Lemmens R
AU  - Poli S
AU  - Wasay M
AU  - Wu T
AU  - Yeşilot N
AU  - Chen J
AU  - Cotelli MS
AU  - Demeestere J
AU  - Duan J
AU  - Ergin N
AU  - Freitas TE
AU  - Gomes A
AU  - den Hertog HM
AU  - Lindgren E
AU  - Martinez-Majander N
AU  - Metanis I
AU  - Miraclin A
AU  - Rani LJ
AU  - Reddy YM
AU  - Saleem S
AU  - Scutelnic A
AU  - Shanmugasundaram S
AU  - van den Wijngaard IR
AU  - Gençdal IY
AU  - van Eekelen R
AU  - Vellema J
AU  - Arnold M
AU  - Neto L
AU  - Middeldorp S
AU  - de Sousa DA
AU  - Jood K
AU  - Putaala J
AU  - Ferro JM
AU  - Coutinho JM
AU  - DOAC-CVT investigators
PY  - 2025
JO  - The Lancet. Neurology
DO  - 10.1016/s1474-4422(24)00519-2
UR  - https://doi.org/10.1016/s1474-4422(24)00519-2
ER  -

APA

A, V. D. M., MS, V. K., T, T., K, K., S, A., F, A., A, A., MA, B., AB, C., DG, C., MR, H., M, H., S, H., X, J., W, K., TJ, K., ES, K., RR, L., R, L., S, P., M, W., T, W., N, Y., J, C., MS, C., J, D., J, D., N, E., TE, F., A, G., HM, D. H., E, L., N, M., I, M., A, M., LJ, R., YM, R., S, S., A, S., S, S., IR, V. D. W., IY, G., R, V. E., J, V., M, A., L, N., S, M., DA, D. S., K, J., J, P., JM, F., JM, C., & investigators, D. (2025). Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study.. The Lancet. Neurology. https://doi.org/10.1016/s1474-4422(24)00519-2

Source records

pubmed · retrieved 2026-09-26T22:13:08.722Z